tag uk-pharma 
pharmaphorum
APRIL 26, 2021
Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. Teijin Pharma is part of Teijin Group, a multinational offering services in high-performance materials, healthcare including pharma and IT.
pharmaphorum
NOVEMBER 16, 2021
NHS patients in England and Wales with drug-resistant epilepsy are in line for access to another treatment option, after NICE recommended routine use of Angelini group company Arvelle Pharma’s Ontozry. Epilepsy affects more than 600,000 people in the UK and for some, seizures can be life-threatening.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 10, 2023
This is not the first treatment to come with a high price tag. Countries with a high willingness for performance-based models, such as the UK, saw this RSA type peak in 2019 before continually declining. million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.
pharmaphorum
SEPTEMBER 15, 2020
Companies like prescription glasses firm Warby Parker, shoe brand Rothy’s and tele-dentistry’s SmileDirectClub have grown up in today’s digitally native environment and can offer some key pointers for pharma. As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus.
Pharmaceutical Technology
DECEMBER 5, 2022
Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In most EU and Commonwealth countries, including the UK, New Zealand and Australia, cannabinoids are legal for medical use.
Pharmaceutical Technology
JULY 14, 2022
Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). The choice of where to launch an orphan drug is an important and difficult decision.
pharmaphorum
NOVEMBER 27, 2022
Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. In recent years, the UK pharmaceutical industry has relied heavily on China and India as providers of active pharmaceutical ingredients. Reducing capacity issues.
Expert insights. Personalized for you.
120 
Let's personalize your content